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BACKGROUND: Acupuncture has been shown to be ef-
fective for the treatment of chronic musculoskeletal back,
neck, and osteoarthritis pain. However, access to acu-
puncture treatment has been limited in medically under-
served and low-income populations.
OBJECTIVE: Acupuncture therapy delivered in groups
could reduce cost and expand access. We compared the
effectiveness of group versus individual acupuncture for
pain and function among ethnically diverse, low-income
primary care patients with chronic musculoskeletal pain.
DESIGN: This was a randomized comparative effective-
ness non-inferiority trial in 6 Bronx primary care commu-
nityhealth centers. Participantswith chronic (> 3months)
back, neck, or osteoarthritis painwere randomly assigned
to individual or group acupuncture therapy for 12 weeks.
PARTICIPANTS: Seven hundred seventy-nine partici-
pants were randomized. Mean age was 54.8 years.
35.3% of participants identified as black and 56.9% iden-
tified as Latino. Seventy-six percent were Medicaid in-
sured, 60% reported poor/fair health, and 37% were un-
able to work due to disability.
INTERVENTIONS: Participants received weekly acu-
puncture treatment in either group or individual setting
for 12 weeks.
MAIN MEASURES: Primary outcome was pain interfer-
ence on the Brief Pain Inventory at 12 weeks; secondary
outcomes were pain severity (BPI), physical and mental
well-being (PROMIS-10), and opiate use. Outcome meas-
ures were collected at baseline, 12 and 24 weeks.
KEY RESULTS: 37.5% of individual arm and 30.3% in
group had > 30% improvement in pain interference (d =
7.2%, 95% CI − 0.6%, 15.1%). Non-inferiority of group
acupuncture was not demonstrated for the primary out-
come assuming a margin of 10%. In the responder
analysis of physical well-being, 63.1% of individual par-
ticipants and 59.5% of group had clinically important
improvement at 12 weeks (d = 3.6%, 95% CI − 4.2%,
11.4%).
CONCLUSIONS: Both individual and group acupuncture
therapy delivered in primary care settings reduced chron-
ic pain and improved physical function at 12 weeks; non-
inferiority of group was not shown.
TRIAL REGISTRATION: Cl in ica l t r ia l s . gov #
NCT02456727
KEY WORDS: pain; acupuncture therapy; health disparities; integrative
medicine.
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INTRODUCTION
The prevalence of chronic pain conditions in the adult US
population ranges from 11 to 47% in large surveys1–8; low
back and neck pain, osteoarthritis (OA), and headache are the
most common.9 Underserved and ethnically diverse popula-
tions are especially at risk for pain and pain undertreatment,5,
10–12 and these disparities are compounded when limited En-
glish proficiency impacts communication.5 Living with chron-
ic pain is associated with impairment of physical and psycho-
logical functioning,13–15 lost productivity,16 and lower socio-
economic status.6
Acupuncture therapy is effective in the treatment of chronic
pain conditions17–20 including chronic low back pain,21–24
neck pain,24–26 and knee pain from osteoarthritis.27–32 A re-
cently updated individual patient data meta-analyses including
over 20,000 patients with chronic pain showed acupuncture to
be significantly better than sham treatment or usual care with
only a 15% reduction in treatment effect at 1 year.33 Acupunc-
ture therapy is supported or recommended as part of compre-
hensive pain care12 by the Agency for Healthcare Research
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and Quality (AHRQ),34 the American College of Physicians
(ACP),35 and the Joint Commission (TJC).36, 37
Acupuncture therapy has been predominantly studied in the
individual setting17; it has been shown to be effective and
feasible for low-income, ethnically diverse, chronic pain
patients delivered in community health center settings.38–40
However, lack of insurance coverage and limited access pose
barriers to implementation in this population. To reduce cost,
increase access, and meet patient demand, group acupuncture
therapy is now being offered across the USA. In group acu-
puncture, patients are treated simultaneously, in a staggered
fashion, situated near and in view of one another. Studies
demonstrate that group acupuncture is acceptable to
patients,38, 41–46 and early studies show it to be effective for
pain.46 However, to date, no studies have compared the effec-
tiveness of group versus individual acupuncture for chronic
pain.47,48 The “Acupuncture Approaches to Decrease Dispar-
ities in Outcomes of Pain Treatment Two Arm Comparative
Effectiveness Trial” (AADDOPT-2) sought to answer this
question in an underserved and ethnically diverse patient
population.
METHODS
Design Overview
AADDOPT-2 was a randomized, non-blinded comparative
effectiveness trial. All participants were referred for acupunc-
ture therapy by primary care providers (PCPs). The study
consisted of 12 weekly sessions (treatment phase) and a 12-
week follow-up phase. The primary hypothesis was that group
was non-inferior to individual treatment for improving pain
interference. Participants were recruited between May 2015
and August 2017. The Institutional Review Board of Albert
Einstein College of Medicine approved the study.
Study Setting
Participating primary care practices are located in the Bronx,
NY, where 85.5% of residents are from an ethnic minority of
whom more than half (56.7%) are Hispanic. Nearly a third of
the population lives below poverty level. The six practices
provide comprehensive primary care; 5 of the 6 are federally
qualified health centers.
Participants
We enrolled adults aged > 21 who received primary care at a
participating health center and had (1) a diagnosis of chronic
pain (> 3 months) due to osteoarthritis of any joint, or chronic
neck or back pain related to non-cancer diagnoses; (2) fluency
in English or Spanish; (3) ability to provide a phone number;
and (4) intent to be available for up to 24 weeks. Exclusions
were current anticoagulant use, and inability to provide in-
formed consent due to mental illness or cognitive impairment.
No minimum pain score was required for inclusion.
Interventions
Participants in both arms continued to receive usual care
for management of chronic pain. Usual care included med-
ical diagnostic evaluation, analgesic drug therapies, recom-
mendations for physical activity, and sometimes referral to
specialist physicians or physical therapy. A detailed de-
scription of the development and implementation of our
acupuncture manualization has been published separate-
ly.49 We deployed a team of 6 licensed acupuncturists
who treated patients on-site in 5 of the 6 participating
health centers; for one site, participants were treated at a
health center nearby due to space constraints. All of the
acupuncturists delivered both group and individual acu-
puncture sessions. The protocol employed “responsive
manualization,” a pragmatic approach that allows for indi-
vidualizing treatment from a consensus-built array of
options.50 The manual had a common set of acupuncture
points with optional points and techniques allowing treat-
ments to be responsive to the heterogenous and evolving
nature of an individual’s condition. All treatment followed
guidelines for safety and correct methodology.51 Reporting
followed Standards for Reporting Interventions in Clinical
Trials of Acupuncture (STRICTA).52 In addition to acu-
puncture needling, the manual also provided for the incor-
poration of therapies often used with acupuncture including
palpation,53, 54 Tui na (a traditional Chinese manual thera-
py),55, 56 Gua sha (unidirectional press stroking of a lubri-
cated area of skin with a smooth, round-edged instru-
ment),46, 57, 58 and extended auricular treatment with ear
seeds (Semen Vaccaria).59–62 Participants were also given
general lifestyle recommendations in terms of diet, the
importance of moving, and external hot and cold exposure.
Randomization and Treatment Arms
The randomization scheme was computer generated by the
study statistician using a random number generator in the SAS
software system. Randomization was stratified by source of
pain: back pain versus other pain with block sizes of 2–4. The
allocation was held by a supervisory staff member who had no
contact with participants. Study allocation was not visible to
enrolling staff, or provided to the patient, until baseline data
was collected. Due to variable wait lists, the range of time from
randomization to starting acupuncture was 0–311 days (mean
26 days). Individual acupuncture sessions were scheduled on
the half hour with the acupuncturist simultaneously working 2
exam rooms. Group participants received treatment in a setting
with up to 6 patients in the group at any one time, seated in
chairs in a large room (conference or multi-use rooms). Initial
treatments in group were scheduled every 20 min, and follow-
up treatments every 15 min. The acupuncturist was present
throughout the entire treatment period and could also adjust or
add treatment. Patients could lean and rest forward on a table
to allow access to the dorsal body.
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Outcomes and Follow-up
All measures were administered via phone in English or
Spanish. Participants did not receive an incentive to attend
acupuncture treatments but did receive modest incentives to
complete the research interviews. The baseline research inter-
view was conducted immediately prior to randomization, in-
cluding demographics and a measure of depressive symptoms,
the Patient Health Questionnaire (PHQ-9).63 The primary
outcome was defined as > 30% improvement in pain interfer-
ence (defined as “the self-reported consequences of pain on
relevant aspects of a person’s life [including] the extent to
which pain hinders engagement with social, cognitive, emo-
tional, physical, and recreational activities”)64 between base-
line and week 12 as measured by the Brief Pain Inventory:
Short Form (BPI). 65,66, A recent review confirms that 30%
improvement in pain represents clinically important change.67
Secondary outcomes included pain severity on the BPI and
quality of life measured by the 10-item Patient-Reported Out-
comes Measurement Information Systems (PROMIS-10)
global health measure, which includes ratings of physical
function and emotional distress.64, 68 We tracked use of opiate
medications using two methods. Patients were asked at base-
line, 12 and 24 weeks if they had a prescription for an opiate
pain reliever from a physician, and if so, the number of days
used in the last week. In addition, we extracted prescriptions
for opiates written and refilled directly from the electronic
medical record (EMR, EPIC tm) using EMR extraction soft-
ware (Clinical Looking Glass™; Emerging Health Informa-
tion Technology; Yonkers, NY). Patient-reported outcomes
were assessed at baseline, 12 and 24 weeks; the 24-week time
point allowed assessment of maintenance of intervention
effects.
Statistical Methods
The study was designed to evaluate whether group was non-
inferior to individual acupuncture for improving pain. The
primary outcome was response to treatment, as defined by a
30% or greater improvement on the BPI pain interference
measure between baseline and 12 weeks. The margin of non-
inferiority was defined as an absolute difference of δ = 10%
(individual–group) in the proportion of patients who
responded to treatment. With a sample size of 282 subjects
per group, the study had 80% power with a one-sided α =
2.5% to conclude that group therapy is non-inferior to indi-
vidual therapy assuming the true response rate in both groups
is 35%. To account for a 20% loss to follow-up rate, the target
enrollment was 350 patients per arm.
Analyses were conducted according to the intent-to-treat
(ITT) approach, followed by the per protocol (PP) method.
The difference in pain interference response rates between the
treatment arms was estimated along with corresponding two-
sided 95% confidence intervals. Non-inferiority of the group
approach relative to the individual approach was declared if
the upper limit of the 95% confidence interval for the true
difference in response rates (individual therapy rate–group
therapy rate) was less than δ, the margin of non-inferiority.
Stratified analysis using the Cochran-Mantel-Haenszel meth-
od was also performed to adjust for the randomization strati-
fication factor, source of pain. Since unstratified and stratified
results were nearly identical, only the former are reported. In
addition, pain interference as measured on the original contin-
uous scale was also analyzed by fitting analysis of covariance
models with treatment group and baseline pain interference
value as predictor variables.
Secondary outcomes, pain severity and global health, were
analyzed using similar approaches. For opiate analgesic use,
we conducted one EMR data extract for all opiate prescrip-
tions for each participant, 6 months after the final participant-
initiated treatment. Standard conversions were used to calcu-
late oral morphine equivalents from extracted prescriptions.69,
70 Quantities were assumed to cover a 30-day supply unless
otherwise specified by the prescriber. Participants were as-
sumed to be taking all available as needed or PRN doses every
day. For subjects with at least one opioid analgesic prescrip-
tion during the study period, the average daily dose of opioids
was compared over the 12 weeks pre-randomization and
weeks 4–16 post-randomization using the Wilcoxon signed-
rank test (the 4 weeks immediately following randomization
were omitted to allow time for the patient to begin treatment
and receive dosing adjustments from their prescriber). The
same analysis was repeated for 24 weeks pre-randomization
compared with 4–28 weeks post-randomization. Proportions
of patients with an opioid prescription were compared across
the same periods using McNemar’s test.
Handling ofMissing Data. Both list-wise deletion andmultiple
imputation (MI) using chained equations were applied to address
missing data and yielded similar findings. Details and results of
the MI approach are in the supplementary table c.
A complete description of the study protocol and statistical
analysis approach will be available in our final study report on
the PCORI website in May 2020.71
RESULTS
Participant Flow
Of 1469 referrals received, 1341 (91.3%) were screened.
Of screened individuals, 41.9% either declined participa-
tion, were lost to follow-up prior to randomization, or
were ineligible. We randomized 779 to group (n = 389)
or individual (n = 390) arms; 73 (9.4%) of individuals who
were eligible completed baseline data and were random-
ized but never initiated acupuncture. In many cases, these
subjects were initially on a wait list for treatment but
subsequently declined to participate when an opening
became available. We scheduled 2.8 patients per hour in
group and 2.0 in individual sessions. Our actual average
number of patients seen per hour was 1.9 for group and
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1.4 for individual; this accounts for set up and break down
time as well as no-shows (Fig. 1).
Rates of loss to follow-up (i.e., those with no follow-up
data collected) were similar in the two arms at 12 weeks
(individual 12.3% and group 12.8%). There were no dis-
cernible patterns of skipped responses. The proportion of
participants with either no survey or skipped questions
resulting in insufficient data to calculate the pain out-
comes (pain interference and pain severity) at each assess-
ment point is provided in Supplementary Table a. Demo-
graphic characteristics of those with and without missing
primary outcome (pain interference) at 12 weeks are also
shown in Supplementary Table b. Missing pain interfer-
ence data was more common among those with high
school education or less, and the mean age of participants
with missing data was 52.8 years compared with 55.6 for
those without missing data.
Participant Baseline Characteristics
For the overall sample (n = 779; see Table 1), the mean age
was 54.8 years. Participants identified as black (35.3%), white
(13.4%), and multiracial (12.3%). Over half identified as
Latino (56.9%); 76% were Medicaid insured, 60% reported
poor/fair health, and 37% were unable to work due to disabil-
ity. Participants had a baseline pain interference score of 6.1.
One-quarter (26.0%) reported having a prescription for an
opiate pain reliever. Group and individual arm participants
did not differ with regard to demographics and baseline meas-
ures. None of the key potential confounders were significantly
different across treatment arms.
Participation in the Intervention by Arm
Among participants who initiated acupuncture, the mean num-
ber of treatments was 8.0 for group and 8.1 for individual (p =
Figure 1 Participant flow in AADDOPT-2 (CONSORT diagram). a No further data collected; b Available for analysis at 12 weeks for primary
outcomes (ITT).
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0.56). The majority (63.7%) attended 8 or more treatments;
there were no differences in failure to initiate acupuncture
(7.7% individual vs. 11% group; p = 0.12) or number of ses-
sions attended by study arm (see Table 2).
Primary Outcome
Table 3 summarizes results for the primary outcome for both the
ITT and PP samples. The PP sample included participants
(63.7% of those who initiated treatment, N = 450) who attended
a “full course” of treatment, defined as 8 or more treatment
sessions as based on expert opinion and largemeta-analyses.33, 72
Per ITT analysis, 37.5% of individual arm and 30.3% of
group arm participants had > 30% improvement in pain inter-
ference at 12 weeks (d = 7.2%, 95% CI − 0.6%, 15.1%). In the
PP sample, the proportion was 39.7% of individual and 34.4%
of group (d = 5.3%; 95% CI − 4.2%, 14.9%). Non-inferiority
of group acupuncture for the primary outcome was not dem-
onstrated in either the ITT or PP analyses since in both anal-
yses the upper limits of the confidence intervals for the differ-
ence in response rates exceeded the non-inferiority margin of
10%.We alsomeasured pain interference at 24 weeks to assess
persistence of effect. In the ITT sample at 24 weeks, 35.0% of
Table 1 Participant Baseline Demographics
Demographic variable Group (n = 389) Individual (n = 390) p value Total (n = 779)
Age, mean (SD) 54.2 (13.8) 55.4 (13.2) 0.19 54.8 (13.5)
Sex (n (%)) 0.73
Female 315 (81.0%) 312 (80.0%) 627 (80.5%)
Male 74 (19.0%) 78 (20.0%) 152 (19.5%)
Spoken language (n (%)) 0.9*
English 292 (78.7%) 290 (78.0%) 582 (78.3%)
Spanish 79 (21.3%) 81 (21.8%) 160 (21.5%)
Other 1 (0.3%) 0 (0.0%) 1 (0.1%)
Ethnicity (n (%)) 0.34*
Hispanic/Latino(a) 219 (56.3%) 224 (57.6%) 443 (56.9%)
Non-Hispanic 168 (43.2%) 159 (40.9%) 327 (42%)
Do not know 2 (0.5%) 6 (1.5%) 8 (1.0%)
Race (n (%)) 0.24*
American Indian/Native 15 (4.0%) 22 (5.8%) 37 (4.9%)
Asian 6 (1.5%) 4 (1%) 10 (1.3%)
Black/African American 141 (36.3%) 134 (34.4%) 275 (35.3%)
White 46 (11.8%) 58 (14.9%) 104 (13.4%)
Multiracial 43 (11.1%) 53 (13.5%) 95 (12.3%)
Other 138 (35.5%) 119 (30.5%) 257 (33%)
Working status (n (%)) 0.24
Unable to work due to disability 143 (36.8%) 147 (37.7%) 290 (37.2%)
Unemployed 58 (14.9%) 44 (11.3%) 102 (13.1%)
Other (employed, retired, etc.) 188 (48.3%) 199 (51%) 387 (49.7%)
Household income support (n (%)) 0.40
Any Support 114 (29.7%) 103 (27.0%) 217 (28.3%)
No Support 270 (70.3%) 279 (73.0%) 549 (71.7%)
Receive SSI (n (%)) 0.47
Yes 177 (45.5%) 217 (55.6%) 394 (50.6%)
Health insurance (n (%)) 0.78
Medicaid 301 (77.4%) 288 (73.8%) 589 (75.6%)
Private 76 (19.5%) 88 (22.6%) 164 (21.1%)
None 8 (2.1%) 8 (2.1%) 16 (2.1%)
Other 4 (1.0%) 6 (1.5%) 10 (1.3%)
Annual income (n (%)) 0.37
< $20,000 183 (47.0%) 179 (45.9%) 362 (46.5%)
$20,000–$39,999 81 (20.8%) 74 (19%) 155 (19.9%)
> $40,000 42 (10.8%) 57 (14.6%) 99 (12.7%)
Do not know/refused 83 (21.3%) 80 (20.5%) 163 (21%)
Opioid prescription by self-report (n (%))
Yes 106 (27.8%) 93 (24.2%) 0.26 199 (26.0%)
Opioid prescription in EMR (n (%))
Yes
Mean opioid MME
Referring condition (n (%))
Back pain 261 (67.1%) 273 (70.0%) 0.38 534 (68.5%)
Neck pain 70 (18.0%) 68 (17.4%) 0.84 138 (17.7%)
Osteoarthritis 94 (24.2%) 112 (28.7%) 0.15 206 (26.4%)
2 or more 77 (22.5%) 91 (25.7%) 0.33 168 (24.1%)
PHQ-9 score, mean (SD) 8.75 (6.02) 8.74 (6.07) 0.98 8.74 (6.04)
Overall PROMIS Global Health Score (n (%)) 0.95
Poor 80 (20.6%) 85 (21.8%) 165 (21.2%)
Fair 152 (39.1%) 145 (37.3%) 297 (38.2%)
Good 111 (28.5%) 104 (26.7%) 215 (27.6%)
Very good 33 (8.5%) 42 (10.8%) 75 (9.6%)
Excellent 13 (3.3%) 13 (3.3%) 26 (3.3%)
*Fisher’s exact test
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individual arm participants and 28.7% in the group arm had >
30% improvement in pain interference (d = 6.3%, 95% CI −
1.5%, 14.0%).
When multiple imputation was applied to address missing
data, non-inferiority of group therapy could not be declared in
either the ITT or PP analyses (supplementary Table c).
Secondary Outcomes
Pain Severity. In the ITT analysis, 34.8% of individual and
30.5% of group participants had > 30% reduction in pain
severity at 12 weeks (d = 4.3%, 95% CI − 3.3%, 11.9%). In
the PP sample, the proportion was 39.2% of individual
compared with 36.3% of group participants (d = 2.8%; 95%
CI − 6.5%, 12.2%). Non-inferiority of group was not demon-
strated in either analysis. About a quarter of both arms had >
30% reduction at 24 weeks (Table 4).
PROMIS 10 Global Health64. In the ITT sample, baseline
physical health T-score was 34.8 in both arms. In the ITTanalysis,
63.1% of individual arm and 59.5% of group participants had
clinically important improvement (defined as a two-point change
in mean T-score)73, 74 at 12 weeks for physical health (d=3.6%,
95% CI − 4.2%, 11.4%). At 24 weeks 55.4% of individual and
50.2% of group still reported clinically important improvement
(d=5.2%, 95% CI − 2.9%, 13.4%). In the PP sample, 67.7% of
individual and 61.3% of group had 2 point or greater improvement
at 12 weeks (d=6.5%, 95% CI − 2.7%, 15.6%); at 24 weeks,
59.0% of individual arm versus 49.7% of group participants still
reported response (d=9.3%, 95% CI − 0.5%, 19.0%).
Minimal changes were observed in mean mental health scores
in both arms, in both the ITT and PP samples. As no minimal
important difference for the mental health subscale has been
established, we used a change of one half standard deviation (5
points) to define “response.”About a quarter of both samples had
clinically important improvement at 12 weeks.
Opiate Use. Based on EMR data, of the 706 participants, 191
had at least one opioid analgesic prescription during the study
period. The proportion of patients with an opioid prescription in
the ITT sample was significantly higher 12 weeks prior to
randomization than in the period 4–16 weeks after in the indi-
vidual arm (16.4% vs. 11.0%, p = 0.003), but not in the group
arm (13.1% vs. 14.3%, p = 0.39). In the PP sample, individual
arm patients had a decrease in the average daily dose of opioid (in
morphine milliequivalents) before and after randomization
(39.1 mg vs. 30.4 mg, p = 0.05) but those in group treatment
did not (13.5 mg vs. 15.2 mg, p = 0.27). Results are similar when
comparing the longer time frames of 24 weeks prior to 4–
28 weeks post-randomization (see supplementary table d). By
self-report, for the total sample, there was no difference in the
proportion using an opiate pain reliever in the past 7 days at
baseline versus 12weeks in either sample (supplemental Table e).
Table 2 Treatment Participation by Study Arm
Group (n = 346) Individual (n = 360) Total (n = 779) p value
Mean (SD) 8.0 (3.4) 8.1 (3.4) 8.1 (3.4) 0.56
Median (Q1, Q3) 9 (6, 11) 9 (6, 11) 9 (6, 11)
No. of treatments
0 43 (11%) 30 (7.7%) 73 (9.4%)
1–7 126 (36.4%) 130 (36.1%) 256 (36.3%) 0.93
≥ 8 220 (63.6%) 230 (63.9%) 450 (63.7%)
Table 3 Primary Outcome: BPI Pain Interference
Outcome measure Intent to treat Per protocol (> 8 treatments)
Group Individual Between group
difference
Group Individual Between group
difference
Baseline
N 385 385 N/A 219 229 N/A
Mean (SD) 6.0 (2.7) 6.1 (2.7) 0.15 (p = 0.44) 5.8 (2.6) 5.8 (2.8) 0.02 (p = 0.94)
Range (min–max) 0–10 0–10 N/A 0–10 0–10 N/A
12 weeks
N 279 297 N/A 194 209 N/A
Mean (SD) 5.1 (3.0) 4.8 (3.1) − 0.33 (p = 0.19) 4.6 (2.9) 4.5 (3.1) − 0.08 (p = 0.79)
Mean change at 12 weeks from
baseline (SD)
− 0.8
(2.6)
− 1.2 (2.6) − 0.37 95% CI (− 0.77,
0.30)
− 1.1
(2.6)
−1.3 (2.7) − 0.16 95% CI (− 0.65,
0.32)
Responders (> 30% improvement) 82
(30.3%)
108
(37.5%)
7.2% 95% CI (− 0.6%,
15.1%)
65
(34.4%)
81 (39.7%) 5.3% 95% CI (− 4.2%,
14.9%)
24 weeks
N 276 292 N/A 186 202 N/A
Mean (SD) 5.3 (2.9) 5.1 (3.1) − 0.23 (p = 0.73) 5.1 (3.0) 4.7 (3.1) − 0.36 (p = 0.44)
Mean change at 24 weeks from
Baseline (SD)
− 0.7
(2.5)
− 1.0 (2.5) − 0.25 95% CI (− 0.66,
0.17)
− 0.8
(2.5)
− 1.1 (2.5) − 0.31 95% CI (− 0.79,
0.17)
Responders (> 30% improvement) 77
(28.7%)
99 (35.0%) 6.3% 95% CI (− 1.5%,
14.0%)
56
(30.8%)
78 (39.6%) 8.8% 95% CI (− 0.8%,
18.4%)
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There is amodest decrease in the PP sample only inmean days of
use in the past week (supplemental Table f).
Adverse Events
No serious adverse events (AE) were reported in either indi-
vidual or group acupuncture cohorts. Fifteen non-serious AEs
were documented including transient pain at a needle site,
short-term exacerbation of chronic pain condition, dizziness
or nausea, with one participant fainting.49
DISCUSSION
We found clinically significant improvement in pain interfer-
ence in both group and individual arms for a substantial
Table 4 Secondary Outcomes
BPI pain severity Intent to treat Per protocol (> 8 treatments)
Group Individual Between group
difference
Group Individual Between group
difference
Baseline
N 389 386 N/A 220 228 N/A
Mean (SD) 6.8 (1.8) 6.8 (1.9) 0.01 (p = 0.96) 6.7 (1.8) 6.8 (1.9) 0.01 (p = 0.94)
Range 0–10 1.5–10 N/A 1.5–10 1.5–10 N/A
12 weeks
N 285 301 N/A 201 213 N/A
Mean (SD) 5.7 (2.5) 5.4 (2.7) − 0.29 (p = 0.17) 5.3 (2.4) 5.1 (2.7) − 0.19 (p = 0.45)
Mean change at 12 weeks from
Baseline (SD)
− 1.1 (2.1) − 1.4 (2.8) − 0.26 95% CI (− 0.61,
0.09)
− 1.4 (2.2) − 1.7 (2.2) − 0.23 95% CI (− 0.65,
0.18)
Responders (> 30% improvement) 87
(30.5%)
104
(34.8%)
4.3% 95% CI (− 3.3%,
11.9%)
73
(36.3%)
83 (39.2%) 2.8% 95% CI (− 6.5%,
12.2%)
24 weeks
N 286 294 N/A 196 204 N/A
Mean (SD) 6.0 (2.6) 5.8 (2.6) − 0.18 (p = 0.72) 5.7 (2.5) 5.5 (2.5) − 0.17 (p = 0.73)
Mean change at 24 weeks from
baseline (SD)
− 0.8 (2.3) − 1.1 (2.2) − 0.23 95% CI (− 0.59,
0.13)
− 1.0 (2.3) − 1.2 (2.3) − 0.17 95% CI (− 0.62,
0.25)
Responders (> 30% improvement) 65
(22.8%)
74
(25.4%)*
2.6% 95% CI (− 4.4%,
9.6%)
48
(24.5%)
56 (27.7%) 3.2% 95% CI (− 5.4%,
11.9%)
PROMIS: Physical health
Baseline
N 385 387 N/A 217 228 N/A
Mean (SD) 34.8 (7.2) 34.8 (7.7) 0.05 (p = 0.92) 35.3 (7.1) 35.2 (7.6) − 0.04 (p = 0.96)
12 Weeks
N 295 308 N/A 207 219 N/A
Mean (SD) 38.5 (8.4) 38.7 (8.3) 0.21 (p = 0.76) 39.4 (8.3) 39.6 (8.1) 0.22 (p = 0.78)
Mean change at 12 weeks from
baseline (SD)
3.6 (7.3) 3.6 (6.5) 0.08 95% CI (− 0.97,
1.13)
3.8 (7.1) 4.2 (6.4) 0.36 95% CI (− 0.87,
1.59)
Responders (≥ 2-point
improvement)
173
(59.5%)
193
(63.1%)
3.6% 95% CI (− 4.2%,
11.4%)
125
(61.3%)
147
(67.7%)
6.5% 95% CI (− 2.7%,
15.6%)
24 weeks
N 287 297 N/A 196 206 N/A
Mean (SD) 37.2 (8.7) 37.8 (8.5) 0.60 (p = 0.4) 38.2 (8.7) 38.7 (8.1) 0.54 (p = 0.52)
Mean change at 24 weeks from
baseline (SD)
2.4 (7.3) 2.7 (6.4) 0.38 95% CI (− 0.69,
1.45)
2.5 (7.1) 3.1 (6.1) 0.64 95% CI (− 0.61,
1.90)
Responders (≥ 2-point
improvement)
142
(50.2%)
164
(55.4%)
5.2% 95% CI (− 2.9%,
13.4%)
96
(49.7%)
121
(59.0%)
9.3% 95% CI (− 0.5%,
19.0%)
PROMIS: Mental health
Baseline
N 385 384 N/A 219 226 N/A
Mean (SD) 42.8 (9.8) 42.4 (9.6) − 0.40 (p = 0.57) 43.6 (9.6) 43.5 (9.7) − 0.09 (p = 0.92)
12 weeks
N 291 308 N/A 204 218 N/A
Mean (SD) 43.8 (9.4) 44.5 (9.6) 0.76 (p = 0.33) 44.4 (9.2) 45.2 (9.3) 0.78 (p = 0.39)
Mean change at 12 weeks from
baseline (SD)
1.1 (8.4) 1.5 (7.1) 0.48 95% CI (− 0.65,
1.61)
0.8 (8.0) 1.4 (6.6) 0.66 95% CI (− 0.61,
1.93)
Responders (≥ 5-point
improvement)
75
(26.0%)
84 (27.6%) 1.6% 95% CI (− 5.6%,
8.7%)
48
(23.6%)
57 (26.5%) 2.9% 95% CI (− 5.4%,
11.2%)
24 weeks
N 288 297 N/A 198 206 N/A
Mean (SD) 43.3 (9.9) 44.1 (9.4) 0.78 (p = 0.33) 44.1 (9.7) 45 (9.0) 0.88 (p = 0.35)
Mean change at 24 weeks from
baseline (SD)
0.8 (7.5) 1.3 (6.9) 0.52 95% CI (− 0.56,
1.61)
0.4 (7.2) 1.4 (6.6) 0.94 95% CI (− 0.30,
2.18)
Responders (≥ 5-point
improvement)
72
(25.3%)
86 (29.2%) 3.9% 95% CI (− 3.4%,
11.1%)
45
(22.8%)
59 (28.9%) 6.1% 95% CI (− 2.5%,
14.6%)
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proportion of participants at 12 weeks in both our ITT and PP
analyses. Pain severity also showed clinically meaningful
improvement in over 30% of participants in both arms, and
global physical health in roughly 60%. Non-inferiority of
group to individual acupuncture was not demonstrated for
either pain interference or severity at 12 weeks; individual
treatment was consistently slightly better than group. Regard-
ing opiate use, based on EMR data, opiate prescriptions de-
clined in the individual arm but not in the group arm when
comparing the 12 weeks pre-intervention to the period 4–
16 weeks post-intervention.
Although our response rates in both arms were slightly lower
than the 40–50% response seen in a large individual patient data
meta-analyses,33, 72 and although we did not demonstrate non-
inferiority of group treatment, our results suggest that both
individual and group acupuncture can be offered safely in the
community health center setting, and that a substantial propor-
tion of patients with chronic pain will have clinically significant
improvement. In light of the many recent guidelines documents
supporting the use of acupuncture as part of comprehensive
pain care and to mitigate opioid risks,34–36, 75, 76 this is an
important finding. We also found that acupuncturists saw on
average 1.9 patients per hour in group sessions compared with
1.4 per hour in individual (35% increase) suggesting a possible
cost advantage to the group model. This may be an underesti-
mate of the increased efficiency of the group model: in well-
managed practice settings (rather than a clinical trial) acupunc-
turists would typically see 2 patients per hour for individual
treatment and 4 patients per hour for group treatment. Finally,
group care provided in a common, multipurpose room reduces
the cost of utilization of individual medical exam rooms, which
are typically in high demand in these settings.
Regarding acceptability of group treatment, there was no
difference in the number of sessions attended for participants
in the two arms, or any difference in treatment initiation after
randomization. Participants who might have had an initial
preference for individual treatment reliably initiated and con-
tinued treatment in the group setting. In qualitative interviews
with participants in both study arms, 77 we identified both
positive (social interaction) and negative (privacy concerns,
mixed-gender groups) elements, but none of these ultimately
affected initiation and continuation of treatment.
A number of factors specific to our treatment setting and
population make the positive response rates particularly mean-
ingful. For both individual and group arms, delivery in busy
community health centers presented challenges. The physical
plant was designed for needs of primary care. Individual treat-
ment occurred in medical exam rooms with tables not designed
for a comfortable supine or prone position. Group sessions
were scheduled in multi-purpose conference roomswith a table
and chairs. Our population was also different in many ways
from those in most clinical trials to date: participants often had
multiple significant comorbidities, including depression,
higher levels of disability and lower functional status, and
significant socioeconomic and biopsychosocial challenges.
These challenges may have contributed to the lower response
rate. A recent trial of yoga versus physical therapy (PT) for
chronic low back pain in an undeserved population found
response rates very similar to those in our study (35%).78 Our
previous study of individual acupuncture in this setting simi-
larly found that roughly 1/3 of participants had a 30% or greater
improvement in pain,79 suggesting that this may be a more
typical response in this population. Regarding the difference in
outcomes between group and individual arms, it is possible that
constraints on the physical environment may have contributed,
in particular, the challenge of treating patients seated in chairs
with limited capacity for accessing acupuncture points on the
trunk and upper legs. A recent pilot trial which provided group
acupuncture in a more optimal setting found a larger proportion
of patients experiencing a clinically significant reduction in
pain and depression.46
Study Limitations
The most significant limitation of this study was that due to
resource limitations, our pragmatic trial design did not include
a third arm representing usual care alone; thus, we cannot
definitively attribute the participants’ benefit to the acupunc-
ture treatment. However, the benefit of acupuncture compared
with both placebo and usual care has been shown elsewhere in
large individual patient data meta-analyses.33, 72 A second
limitation was the suboptimal physical setting of group acu-
puncture delivery. This could have biased results away from
non-inferiority of group over individual. In future implemen-
tation, this limitation could be mitigated by the addition of
more comfortable chairs and one or two mobile treatment
tables. The ITT group includes 73 people who were random-
ized but never initiated treatment, biasing ITT results toward
less effective overall. There were several limitations to use of
EMR data to examine opioid analgesic use. First, participants
possibly obtained prescriptions outside of our health system
which would have been unavailable for analysis. Second, the
assumption was made that participants used all as-needed
doses available to them by prescription, which may not be
accurate. Although these limitations would theoretically apply
equally to both groups, based on the fact that the standard
deviation was extremely wide and that opioid utilization was a
secondary outcome for which we were not adequately pow-
ered, our findings on opioids should be seen as hypothesis-
generating for future research rather than definitive.
CONCLUSIONS
Our results demonstrate that individual and group acu-
puncture can be offered safely in the community health
center setting, that acceptability to patients and clinicians
is very high, and that a substantial proportion of patients
with chronic pain will have clinically significant improve-
ment in both pain and overall physical health. Based on
these results, acupuncture therapy should be offered as
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part of pain care to underserved populations in the prima-
ry care setting. Non-inferiority of group treatment was not
demonstrated, suggesting that further research is needed
on the optimal strategy for delivering group acupuncture
in this context to consider it as effective as individual
treatment.
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